Abstract:Background: Conventional cytogenetics only analyzes metaphase cells and this analysis is affected by chromosome number and quality. A large mass of metaphase or interphase cells can be detected by fluorescence in situ hybridization on chromatosome and bone marrow smears to examine the number and structure of chromatosome. Objective: To test chromosome abnormality by fluorescence in situ hybridization and compare with the results from conventional cytogenetic analysis (CCA) in myelodysplastic syndrome (MDS). Design, Time and Setting: A case analysis was conducted at the Shenzhen Hospital of Peking University from August 2006 to September 2007. Participants: Forty-eight MDS patients, who had been preliminarily diagnosed according to FAB criteria, followed up and received chromatosome examination, were enrolled at the Shenzhen Hospital of Peking University. Simultaneously, five iron deficiency anemia patients were included as controls. Bicolor probe and CEP8 SpectumAqua probe were purchased from Vysis. Methods: Bone marrow samples received CCA by R differential staining technique. Slide was prepared by direct or short-term culture method, at least 20 karyotypes in each sample. Remaining samples received fluorescence in situ hybridization. Using airdrying, fluid was prepared at the ratio of 1:2:7 (probe: water: hybrid buffer solution), dropped in the hybrid region of the slide. Red/green fluorescence hybrid signal of interphase cells were observed under a fluorescent microscope and color filter glass, 200 in each sample. Main Outcome Measures: Abnormal positive rate of bone marrow cells was measured by two techniques. Results: Of 48 MDS patients, 38 survived after 24 months of follow-up. Using CCA, karyotype abnormalities were found in 18 (37.5%) of 48 cases, among which complex karyotypes were found in 4 (8.3%) cases, a deletion of chromosome 5/a deletion of the long arm of chromosome 5 (-5/5q-) in 5 (10.4%) cases, -7/7q- in 5 (10.4%) cases, trisomy 8 in 8 (16.6%) cases, 20q- in 2 (4.6%) cases, unconsistent translocations in 3 (6.2%) cases. Fluorescence in situ hybridization detected 5q- in 2 additional cases, 7q- in 5 additional cases, -7 in 1 additional case, +8 in 12 addition cases in addition to confirming -5/5q-, -7/7q- and +8 found by CCA in 5, 5, 8 cases raising the detection rates of -5/5q-, -7nq- and +8 to 14.5%, 22.9% and 41.7%, respectively. Conclusion: The fluorescence in situ hybridization with panel probes is more sensitive and specific for detection of chromosome 5, 7, 8 abnormalities in MDS patients than that of CCA. But it cannot replace CCA, because it cannot detect the chromosome translocation. This indicates that their combination can increase the positive rate of chromosome abnormality in MDS patients.

Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies

Data on MECOM rearrangement-driven chromosomal aberrations in myeloid malignancies

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations

Co-mutation Landscape and Its Prognostic Impact on Newly Diagnosed Adult Patients with NPM1 Mutated De Novo Acute Myeloid Leukemia.

3Q26.2/mecom Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features

Comprehensive Profiling of MDM2/TP53 Genomic Aberration in Chinese Patients with Diverse Malignancies.

Development of a 27‐color Panel for the Detection of Measurable Residual Disease in Patients Diagnosed with Acute Myeloid Leukemia

[Clinical application of BCR/ABL probes in myeloproliferative disorders].

Multiplex Fluorescence Melting Curve Analysis For Mutation Detection With Dual-Labeled, Self-Quenched Probes

Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient‐specific iPSCs

A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia

CBFB Break-Apart FISH Testing: an Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management

Molybdenum Disulfide@5-Carboxyfluorescein-probe Biosensor for Unamplified Specific Fragment Detection in Long Nucleic Acids Based on Magnetic Composite Probe-Actuated Deblocking of Secondary Structure.

[Detection of BCR/ABL Fusion Gene and ASS1 Gene Deletion by Using Tricolor Dual-fusion Probe].

Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements

Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

A branch-migration based fluorescent probe for straightforward, sensitive and specific discrimination of DNA mutations.

[M-FISH Technique in Diagnosis and Prognostic Analysis for Acute Leukemia with Complex Chromosomal Aberrations].

Xmap Array Microspheres Based Stem-Loop Structured Probes As Conformational Switches for Multiplexing Detection of Mirnas

Rapid Detection of Immunoglobulin Heavy Chain Gene Rearrangement by PCR and Melting Curve Analysis Using Combined FR2 and FR3 Primers